LIMONTA, PATRIZIA
LIMONTA, PATRIZIA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
2024 F. Fontana, M. Sommariva, M. Anselmi, F. Bianchi, P. Limonta, N. Gagliano
Adipocytes reprogram prostate cancer stem cell machinery
2023 F. Fontana, M. Anselmi, P. Limonta
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
2023 F. Fontana, M. Anselmi, P. Limonta
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma
2023 F. Fontana, C. Macchi, M. Anselmi, A.S. Rizzuto, M. Ruscica, P. Limonta
Cellula tumorale
2022 P. Limonta
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
2022 F. Fontana, M. Anselmi, P. Limonta
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
2022 M. Anselmi, F. Fontana, M. Marzagalli, N. Gagliano, M. Sommariva, P. Limonta
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
2022 F. Fontana, M. Anselmi, P. Limonta
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
2022 F. Fontana, M. Anselmi, P. Limonta
Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes
2022 F. Fontana, M. Anselmi, E. Carollo, P. Sartori, P. Procacci, D. Carter, P. Limonta
In vitro 3D cultures to model the tumor microenvironment
2021 F. Fontana, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
2021 F. Fontana, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta
Cancer Stem Cells—Key Players in Tumor Relapse
2021 M. Marzagalli, F. Fontana, M. Raimondi, P. Limonta
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
2021 F. Fontana, P. Limonta
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
2021 M. Raimondi, F. Fontana, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells
2020 F. Fontana, M. Raimondi, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Gonadotropin-releasing hormone receptors in prostate cancer : molecular aspects and biological functions
2020 F. Fontana, M. Marzagalli, M.M. Marelli, M. Raimondi, R.M. Moretti, P. Limonta
The emerging role of paraptosis in tumor cell biology: Perspectives for cancer prevention and therapy with natural compounds
2020 F. Fontana, M. Raimondi, M. Marzagalli, A. Di Domizio, P. Limonta